17:38

Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape

26:35

ASH 2024: Updates on CLL

30:09

Highlights from ASH 2023: A Canadian Perspective on CLL

27:47

UPDATES from ASH 2024 - TREATMENT OF CLL

22:22

Immunotherapy for Kidney Transplant Patients with Skin Cancer

31:01

Canada Real estate market 'is nuts'

41:29

Precision Medicine Series: Ep15: Biomarkers in Upper GI Cancers

33:43

First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: 1L LA/mUC